Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine

Details for Australian Patent Application No. 2012201640 (hide)

Owner Vivus, Inc.

Inventors Najarian, Thomas; Tam, Peter; Wilson, Leland; Peterson, Craig

Agent FB Rice

Pub. Number AU-A-2012201640

Parent 2008267058

Filing date 20 March 2012

Wipo publication date 5 April 2012

International Classifications

A61K 31/7048 (2006.01)

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

5 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201640

5 April 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201641-Systems and methods for formation and harvesting of nanofibrous materials

2012201639-Surgical mesh-like implant